Wednesday, April 7, 2010 as of 11:14 AM ET
King Pharmaceuticals (), was the world's 39th largest pharmaceutical company, based in Bristol, Tennessee.
Read More at Wikipedia ›Morgan Stanley Smith Barney Chief Investment Strategist David Darst on why the economy and markets are facing a soft patch, but not a full-fledged double-dip recession.
FBN's Shibani Joshi on Pfizer's acquisition of the pharmaceutical company.
FBN's Connell McShane on the potential acquisition of the cosmetics company.
Stock futures were pointing to a lower opening as traders await the release of minutes from the Federal Reserve ’s September meeting and ahead of earnings from bellw...
Pfizer Inc ( PFE ) reached a deal to buy drugmaker King Pharmaceuticals Inc ( KG ) for $3.6 billion in cash, aiming to boost revenue before it loses patent protecti...
